ConductScience.org, home

Paper36175603

Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer.

Shanmugam G and 4 others. Med Oncol, 2022. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer. Papers, record 36175603. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36175603

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer.
PubMed
Journal
Med Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.5
iCite
Revised in PubMed
2026-10-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shanmugam GGeethahttps://orcid.org/0000-0003-3035-6190
2Das SSumana
3Paul SSambuddha
4Rakshit SSudeshnahttps://orcid.org/0000-0002-7496-3155
5Sarkar KKoustavhttps://orcid.org/0000-0002-0696-6688

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigen-Presenting CellsMajor topic
Lung NeoplasmsMajor topic
Antigen Presentation
Humans
Immunotherapy
Tumor-Associated Macrophages

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ECR/2016/000965Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Govt. of IndiaPubMed

Source PubMed

Download CSV of grants

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118281925Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses.Cancer Immun2008https://conductscience.org/library/papers/18281925PubMed
225698555Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer.Int Immunopharmacol2015https://conductscience.org/library/papers/25698555PubMed
322086517M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma.Clinics (Sao Paulo)2011https://conductscience.org/library/papers/22086517PubMed
415976491TLR signalling and the function of dendritic cells.Chem Immunol Allergy2005https://conductscience.org/library/papers/15976491PubMed
518799141Mechanisms and consequences of dendritic cell migration.Immunity2008https://conductscience.org/library/papers/18799141PubMed
612576442Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.Clin Cancer Res2003https://conductscience.org/library/papers/12576442PubMed
716467102Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.Clin Cancer Res2006https://conductscience.org/library/papers/16467102PubMed
811923611Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.Ann Surg2002https://conductscience.org/library/papers/11923611PubMed
930444051Advances in evidence-based medicine for immunotherapy of non-small cell lung cancer.J Evid Based Med2018https://conductscience.org/library/papers/30444051PubMed
1021681372Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer.Cancer Immunol Immunother2011https://conductscience.org/library/papers/21681372PubMed
1126787825Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator.Cancer Immunol Res2016https://conductscience.org/library/papers/26787825PubMed
1228848053Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.Cancer Immunol Res2017https://conductscience.org/library/papers/28848053PubMed
1311904734Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen.Cancer Immunol Immunother2002https://conductscience.org/library/papers/11904734PubMed
1420420527INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.Expert Opin Biol Ther2010https://conductscience.org/library/papers/20420527PubMed
1520429924Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.BMC Cancer2010https://conductscience.org/library/papers/20429924PubMed
1624043896Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells.J Immunol2013https://conductscience.org/library/papers/24043896PubMed
1724070386Diversity of pathogen sensors in dendritic cells.Adv Immunol2013https://conductscience.org/library/papers/24070386PubMed
1828129580Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer.Transl Oncol2017https://conductscience.org/library/papers/28129580PubMed
1927097970Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.Radiat Oncol2016https://conductscience.org/library/papers/27097970PubMed
2015771572IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.Annu Rev Immunol2005https://conductscience.org/library/papers/15771572PubMed

See all 93 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42724375Midkine restrains T-cell mediated anti-tumor immunity by suppressing macrophage M1 polarization in lung adenocarcinoma.Transl Cancer Res2026https://conductscience.org/library/papers/42724375PubMed
41372758CYP27A1 suppresses brain metastasis via ferroptosis in lung adenocarcinoma: a six-gene signature predicting the immunotherapy response and clinical outcomes.Cancer Cell Int2025https://conductscience.org/library/papers/41372758PubMed
40700281The Impact of Age on the Effectiveness of Immune Checkpoint Inhibitors Therapy in Patients with Metastatic Non-Small-Cell Lung Cancer.Geriatrics (Basel)2025https://conductscience.org/library/papers/40700281PubMed
39492834Immunometabolism: signaling pathways, homeostasis, and therapeutic targets.MedComm (2020)2024https://conductscience.org/library/papers/39492834PubMed
37189748Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy.Biomedicines2023https://conductscience.org/library/papers/37189748PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36175603

GET https://conductscience.org/api/papers/v1/36175603/references?page=2